Literature DB >> 14710377

The role of evoked potential monitoring in operative management of type I and type II thoracoabdominal aortic aneurysms.

Michael J Jacobs1, Werner H Mess.   

Abstract

Spinal cord ischemia with subsequent paraplegia remains the most dreaded and impressive complication following thoracoabdominal aortic aneurysm repair. Protective measures, such as cerebrospinal fluid drainage, distal aortic perfusion, and epidural cooling, have significantly reduced paraplegia rate. A major impediment is the inability to assess the efficacy of reattaching intercostal arteries or the contributing value of the adjunctive procedures during the operation. Monitoring motor-evoked potentials is a reliable technique to assess spinal cord integrity, dictating surgical strategies to restore and maintain blood supply to the gray matter. Based on motor-evoked potentials, hemodynamic and operative maneuvers during thoracoabdominal aortic aneurysm repair resulted, in our experience, in prevention of neurologic deficit in 98% of patients.

Entities:  

Mesh:

Year:  2003        PMID: 14710377     DOI: 10.1053/s1043-0679(03)00084-4

Source DB:  PubMed          Journal:  Semin Thorac Cardiovasc Surg        ISSN: 1043-0679


  3 in total

Review 1.  Intraoperative motor evoked potential monitoring: overview and update.

Authors:  David B Macdonald
Journal:  J Clin Monit Comput       Date:  2006-07-11       Impact factor: 2.502

2.  Transcutaneous near-infrared spectroscopy for monitoring spinal cord ischemia: an experimental study in swine.

Authors:  Koichi Suehiro; Tomoharu Funao; Yohei Fujimoto; Akira Mukai; Mitsuyo Nakamura; Kiyonobu Nishikawa
Journal:  J Clin Monit Comput       Date:  2016-08-27       Impact factor: 2.502

3.  Neurophysiological and paraspinal oximetry monitoring to detect spinal cord ischemia in patients during and after descending aortic repair: An international multicenter explorative study.

Authors:  Cheryl N Oostveen; Patrick W Weerwind; Paul P E Bergs; Jürg Schmidli; Roman Bühlmann; Joerg C Schefold; Balthasar Eberle; Jolanda Consiglio; Gereon Schälte; Drosos Kotelis; Angelique W H Hollands; Wolfgang F F A Buhre; Geert Willem H Schurink; Michael J Jacobs; Walther N K A van Mook; Werner H Mess; Nadia A Sutedja
Journal:  Contemp Clin Trials Commun       Date:  2020-02-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.